Κυριακή 27 Μαΐου 2018

Anterior disc derangement with reduction of the temporomandibular joint: a case report

Temporomandibular dysfunction involving anterior disc derangement with or without reduction, secondary to posterior ligament insufficiency is typically managed conservatively with success in a majority of pati...

https://ift.tt/2GWxPLI

Breast and cervical cancer incidence and mortality trends in Russia 1980–2013

S18777821.gif

Publication date: August 2018
Source:Cancer Epidemiology, Volume 55
Author(s): Anton Barchuk, Alexander Bespalov, Heini Huhtala, Tuvshinjargal Chimed, Irina Laricheva, Alexey Belyaev, Freddie Bray, Ahti Anttila, Anssi Auvinen
BackgroundBreast and cervical cancer are among the leading causes of preventable cancer deaths in women in Russia. The aim of this study is to analyze changes in breast and cervical cancer incidence and mortality trends using data from the Russian State Cancer Registry.MethodsThe age-standardized rates of cervical cancer incidence (1993–2013) and mortality (1980–2013) were analyzed using piecewise linear regression. Age-period-cohort models were used to estimate the temporal effects and provide future predictions.ResultsBreast and cervical cancer incidence rates uniformly increased over two decades from 33.0 to 47.0 per 100,000 and from 10.6 to 14.2 per 100,000, respectively. Breast cancer mortality rates however declined from 17.6 to 15.7 in 2013, while cervical cancer mortality increased steadily from 5.6 to 6.7. Breakpoints in the risk occurred in cohorts born 1937–1953, indicating a recent generational decrease in breast cancer mortality, but a concomitant increase in cervical cancer. Cervical cancer has already surpassed breast cancer in terms of years of life lost (YLL) (23.4 per death vs 18.5 in 2009–2013), while future projections suggest that the annual YLL could reach 1.2 million for cervical cancer and (decline to) 1.8 million for breast cancer by the year 2030.ConclusionThe temporal patterns of breast cancer incidence and mortality in Russia are in line with other countries in Europe, although cervical cancer rates and the risk of occurrence in recent generations is rapidly increasing; these trends underscore the need to place immediate priority in national cervical vaccination and screening programs.



https://ift.tt/2xgZwPZ

Problems and solutions in IGRT for cervical cancer

Publication date: Available online 26 May 2018
Source:Reports of Practical Oncology & Radiotherapy
Author(s): Iván Ríos, Ilse Vásquez, Elsa Cuervo, Óscar Garzón, Johnny Burbano
The contribution of Image-guided Radiotherapy (IGRT) to modern radiotherapy is undeniable, being the way to bring into daily practice the dosimetric benefits of Intensity-Modulated Radiotherapy (IMRT). Organ and target motion is constant and unpredictable at the pelvis, thus posing a challenge to the safe execution of IMRT. There are potential benefits of IMRT in the radical treatment of cervical cancer patients, both in terms of dose escalation and decrease of toxicity. But it is essential to find IGRT solutions to control the aspects that can lead to geographic miss targeting or organs at risk (OAR) overdose. This review seeks to describe the problems and possible solutions in the clinical implementation of IMRT/IGRT protocols to treat intact cervical cancer patients.



https://ift.tt/2LBjh86

Definitive Local Therapy is Associated with Improved Overall Survival in Metastatic Cervical Cancer

S18798500.gif

Publication date: Available online 26 May 2018
Source:Practical Radiation Oncology
Author(s): Sriram Venigalla, David M. Guttmann, Zachary D. Horne, Ruben Carmona, Jacob E. Shabason, Sushil Beriwal
PurposeDefinitive local therapy is often used in metastatic cervical cancer to reduce morbidity associated with local tumor progression. However, the potential benefit of this therapeutic approach has not been rigorously investigated. We hypothesized that definitive local therapy would be associated with improved overall survival (OS) in metastatic cervical cancer.Methods and MaterialsPatients ≥18 years with newly diagnosed metastatic cervical cancer treated with chemotherapy were identified from the National Cancer Database. Patients were dichotomized into the following cohorts1: definitive local therapy, defined as either concurrent chemoradiotherapy or definitive surgery, or2 conservative therapy, defined as systemic therapy with or without palliative radiotherapy. The association between definitive local therapy and OS was assessed using propensity score-weighted Cox proportional hazards models. Potential unmeasured confounding was assessed through sensitivity analyses. Factors associated with receipt of definitive local therapy were identified with multivariable logistic regression.ResultsOf 2,838 total patients, 1,194 (42%) and 1,644 (58%) were treated with definitive local therapy and conservative therapy, respectively. Receipt of definitive local therapy was statistically significantly associated with less comorbidity, lower clinical T stage, and node negative disease. Compared to conservative therapy, definitive local therapy was associated with improved OS (HR=0.57, 95% CI: 0.52-0.62, p ≤ 0.001). Median OS was 19.2 months in the definitive local therapy cohort and 10.1 months in the conservative therapy cohort. These findings were robust to potential unmeasured confounding in sensitivity analyses and on landmark analyses of patients surviving at least 12 months (HR=0.71, 95% CI: 0.62 – 0.82, p ≤ 0.001).ConclusionsDefinitive local therapy is associated with improved OS in patients with metastatic cervical cancer. These findings suggest a novel setting for the use of definitive local therapy in the metastatic setting.



https://ift.tt/2ISNkdO

Androgen blockade based clinical trials landscape in triple negative breast cancer

Publication date: Available online 25 May 2018
Source:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Author(s): Yaqin Shi, Fang Yang, Doudou Huang, Xiaoxiang Guan
Androgen receptor (AR) targeted treatment has shown promising preliminary results in triple negative breast cancer (TNBC). Identification of AR-associated signaling pathways is of great significance for in-depth understanding of their roles in pathogenesis of TNBC. To meet this objective, preclinical and clinical studies were conducted to clarify the biological interactions of AR signaling and combination strategies based on AR-targeted therapy. Biologically, AR signaling in TNBC which not only interacts with a network of key pathways, involving PI3K/AKT/mTOR, cell cycle, and DNA damage repair pathways, but mediates pivotal processes of tumor initiation and immunogenic modulation, may present an opportunity to overcome the insensitivity of single AR-targeted therapy. Research in investigating androgen-blockade based combination therapy in this aggressive tumor has demonstrated promising benefit in preclinical studies, and comparable clinical trials of combined strategies with CDK4/6 inhibitors, PI3K inhibition, chemotherapy, and immunotherapy, are ongoing. Accordingly, clinical interpretation of AR-related biological interactions, aiming at combined blockade of the signaling pathways may pave a new way for endocrine-based therapy in the treatment of TNBC.



https://ift.tt/2saAz3I

Mitochondria in Cancer metabolism, an organelle whose time has come?

Publication date: Available online 26 May 2018
Source:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Author(s): Rebecca G. Anderson, Lais P. Ghiraldeli, Timothy S. Pardee
Mitochondria have long been controversial organelles in cancer. Early discoveries in cancer metabolism placed much emphasis on cytosolic contributions. Initial debate focused on if mitochondria had a role in cancer formation and progression at all. More recently the contributions of mitochondria to cancer development and progression have become firmly established. This has led to the identification of novel targets and inhibitors being studied as new therapeutic approaches. This review will summarize the role of mitochondria in cancer and highlight several agents under development.



https://ift.tt/2ISwBTy

Isolated Knee Arthritis as Early and Only Symptom of Whipple’s Disease

We report a case of isolated Whipple's disease involving the knee of a 64-year-old female patient who presented recurrent monoarthritis whose origin was not clear. Initially, the cause of the gradually invalidating symptoms was related to a meniscal lesion and a diffuse minor grade chondropathy, but pain and functional impairment suggested that more exams were needed. Biopsies were performed during arthroscopy. The histology showed highly inflammatory infiltrates with PAS staining negative for Tropheryma while PCR revealed the infection with Tropheryma whipplei. This, following the recommendation of a rheumatologist and infectious disease specialist, led to biopsies of the gastrointestinal tract and analysis of the cerebrospinal fluid that showed no other organ involvement. This confirms the scientific literature that an isolated monoarthritis without involvement of the gastrointestinal tract caused by this bacterium is rare but can occur as an early manifestation of potentially fatal systemic disease. Moreover, a review of the scientific literature showed the uncertainty about epidemiology of this rare disease, suggesting that more and specific data are required.

https://ift.tt/2KYQTvg